Fasenra Pen 30 mg/mL single-dose autoinjector Images
Generic Name: benralizumab
This medication has been identified as Fasenra Pen 30 mg/mL single-dose autoinjector. It is supplied by AstraZeneca.
Fasenra is used in the treatment of Eosinophilic Granulomatosis with Polyangiitis; Asthma and belongs to the drug class interleukin inhibitors. Fasenra 30 mg/mL single-dose autoinjector is not a controlled substance under the Controlled Substances Act (CSA).
Images of medication
Fasenra Pen
- Generic Name
- benralizumab
- Strength
- 30 mg/mL single-dose autoinjector
- Availability
- Prescription only
- Drug Class
- Interleukin inhibitors
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- AstraZeneca
- National Drug Code (NDC)
- 00310-1830
See also:
Nucala
Nucala is used to treat severe eosinophilic asthma, eosinophilic COPD, chronic rhinosinusitis with ...
Reviews & ratings
Mepolizumab
Mepolizumab is used to treat several eosinophil-related conditions including Hypereosinophilic ...
Reviews & ratings
More about Fasenra (benralizumab)
- Check interactions
- Compare alternatives
- Reviews (76)
- Drug images
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- FDA approval history
- Drug class: interleukin inhibitors
- Breastfeeding
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.